Ticker Details
Atea Pharmaceuticals, Inc.
IPO Date:	October 30, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$465.28M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.39 | 2.67%
Avg Daily Range (30 D):	$0.17 | 3.15%
Avg Daily Range (90 D):	$0.12 | 2.67%

Institutional Daily Volume
Avg Daily Volume:	.66M
Avg Daily Volume (30 D):	.47M
Avg Daily Volume (90 D):	.41M

Trade Size
Avg Trade Size (Sh.):	115
Avg Trade Size (Sh.) (30 D):	66
Avg Trade Size (Sh.) (90 D):	76

Institutional Trades
Total Institutional Trades:	749
Avg Institutional Trade:	$1.95M
Avg Institutional Trade (30 D):	$1.19M
Avg Institutional Trade (90 D):	$1.36M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.57M
Avg Closing Trade (30 D):	$1.88M
Avg Closing Trade (90 D):	$1.89M
Avg Closing Volume:	185.79K

News

Feb 24, 2026 @ 12:00 PM Atea Pharmaceuticals Presents Preclinical Results ... Source: Na

Nov 7, 2025 @ 1:00 PM Atea Pharmaceuticals Presents New Data Supporting ... Source: Atea Pharmaceuticals

Nov 5, 2025 @ 12:00 PM Atea Pharmaceuticals to Host Third Quarter 2025 Fi... Source: Jonae Barnes

Jul 31, 2025 @ 11:00 AM Atea Pharmaceuticals to Host Second Quarter 2025 F... Source: Atea Pharmaceuticals

Jun 24, 2025 @ 11:00 AM Atea Pharmaceuticals Announces Continued Advanceme... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.94	$-.57	$-1.94
Diluted EPS	$-1.94	$-.57	$-1.94
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-158.35M	$-44.87M	$-158.35M
Operating Income / Loss	$-180.89M	$-54.93M	$-180.89M
Cost of Revenue
Net Cash Flow	$31.02M	$18.37M	$31.02M
PE Ratio

Splits
Feb 14, 2018	1:11